Connect with us

Published

on

WHO Confirms That Three West African Countries Introduce Malaria Vaccine—-The World Health Organisation (WHO) says the Republic of Benin, Liberia and Sierra Leone have launched a large-scale rollout of the life-saving malaria vaccine targeting millions of children across the three West African nations.

WHO said this in a statement as the world celebrates the  17th World Malaria Day  with theme: “Advancing health equity, gender equality and human rights,”.

The world health body said that the vaccine rollout, announced on World Malaria Day, seeks to further scale up vaccine deployment in the African region.

“Today’s launch brings to eight the number of countries on the continent to offer the malaria vaccine as part of the childhood immunisation programmes, extending access to more comprehensive malaria prevention.

“Several of the more than 30 countries in the African region that have expressed interest in the vaccine are scheduled to roll it out in the 2025 .

“This is through support from Gavi, the Vaccine Alliance, as efforts continue to widen its deployment in the region in coordination with other prevention measures such as long-lasting insecticidal nets and seasonal malaria chemoprevention,” it said.

According to it, Benin, which received 215,900 doses, has added the malaria vaccine to its Expanded Programme on Immunisation.

It said that the  malaria vaccine should be provided in a schedule of four doses in children from around five months of age.

“The introduction of the malaria vaccine in the Expanded Programme on Immunization for our children is a major step forward in the fight against this scourge.

Prof Benjamin Hounkpatin, Minister of Health,  Benin   reassure that the malaria vaccines are safe and effective and contribute to the protection of the children against the serious and fatal diseases.

Hounkpatin said that  in Liberia, the vaccine was launched in the southern Rivercess County and would be rolled out afterwards in five other counties which have high malaria burden.

” At least 45 000 children are expected to benefit from the 112 000 doses of the available vaccine,”  he said.

Also, Dr Louise Kpoto, Liberia’s Minister of Health said  for far too long, malaria has stolen the laughter and dreams of their children.

“But today, with this vaccine and the unwavering commitment of our communities, healthcare workers and our partners, including GAVI, UNICEF and WHO, we break the chain.

“We have a powerful tool that will protect them from this devastating illness and related deaths, ensuring their right to health and a brighter future.

“Let’s end malaria in Liberia and pave the way for a healthier, more just society,”  Kpoto said.

According to her , two safe and effective vaccines  RTS,S and R21  recommended by WHO , are  a breakthrough for child health and malaria control.

She said that a pilot malaria vaccine programme in Ghana, Kenya and Malawi reached over two million children from 2019 to 2023.

According to her ,such shows a significant reduction in malaria illness and a 13 per cent drop in overall child mortality and substantial reductions in hospitalisations.

Again, Dr Austin Demby, Minister of Health of Sierra Leone  said that in   Sierra Leone, the first doses were administered to children at a health centre in Western Area Rural where the authorities kicked off the rollout of 550 000 vaccine doses.

“The vaccine will then be delivered in health facilities nationwide.

“With the new, safe and efficacious malaria vaccine, we now have an additional tool to fight this disease. In combination with insecticide-treated nets, effective diagnosis and treatment, and indoor spraying, no child should die from malaria infection,”   Demby  said

According to him, malaria remains a huge health challenge in the African region, which is home to 11 countries that carry approximately 70 per cent of the global burden of malaria.

“The region accounted for 94% of global malaria cases and 95% of all malaria deaths in 2022, according to the World Malaria Report 2023,” he said.

Dr Matshidiso Moeti, WHO Regional Director for Africa said that African region was advancing in the rollout of the malaria vaccine ,  a game-changer in the fight against the deadly disease.

“Working with our member states and partners, we’re supporting the ongoing efforts to save the lives of young children and lower the malaria burden in the region,” she said.

Ms Aurelia Nguyen, Chief Programme Officer at Gavi, the Vaccine Alliance,  says “Today we celebrate more children gaining access to a new lifesaving tool to fight one of Africa’s deadliest diseases.

“This introduction of malaria vaccines into routine programmes in Benin, Liberia, and Sierra Leone alongside other proven interventions will help save lives and offer relief to families, communities and hard-pressed health systems,” she said.

Nguyen  said that progress against malaria has stalled in these high-burden African countries since 2017 due to factors including climate change, humanitarian crises, low access to and insufficient quality of health services, gender-related barriers, biological threats such as insecticide and drug resistance and global economic crises.

She said that other are fragile health systems and critical gaps in data and surveillance have compounded the challenge.

0Shares
Continue Reading
Click to comment

Leave a Reply

News

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India

Published

on

Nipah Virus Cases Emerge in Eastern India

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India—-Sri Lanka has stepped up monitoring measures following reports of a Nipah virus cluster in India’s eastern state of West Bengal.

Health authorities across parts of Asia have also heightened vigilance over the emerging situation, the Daily Mirror reported.

Health officials said Sri Lanka is tracking developments at the regional level and remains in contact with international health monitoring systems.

While no cases have been reported locally, authorities have indicated that preparedness measures are in place should the situation evolve.

The alert follows confirmation by Indian authorities of at least five Nipah virus infections in West Bengal, including cases among healthcare workers.

The development has prompted several countries in the region to strengthen preventive measures, particularly at international airports.

Nipah virus is a zoonotic disease transmitted between animals and humans and, in some instances, through human-to-human contact.

It is classified as a priority pathogen by the World Health Organisation due to its epidemic potential and the severity of illness it can cause. Past outbreaks of the Nipah virus have been associated with high fatality rates, ranging from 40 per cent to 75 per cent. (Xinhua/NAN)

0Shares
Continue Reading

Health & Wellbeing

EL-LAB Limited Marks 2025 World Quality Week With innovation

Published

on

EL-LAB Limited Marks 2025 World Quality Week With innovation

EL-LAB Limited Marks 2025 World Quality Week With innovation

 

EL-LAB Medical Diagnostics and Research Centre, Nigeria’s leading ISO-certified diagnostic centre, today announced its dedication to global quality standards, marking World Quality Week 2025 with the theme “Quality: Think differently” and highlighting its ISO 15189:2022 accreditation.

The centre, which was established in 1998 (27 years ago), has provided advanced medical testing services across Lagos State and continues to contribute significantly to the development of the Nigerian health sector.

Quality: The Silent Foundation of Clinical Decisions

In a statement issued by the company, Mrs. Blessing Nwakobi, Quality Assurance Manager, emphasized that Quality Assurance is the cornerstone of reliable medical diagnosis.

“In healthcare, laboratories are the silent foundation of clinical decisions. Most medical diagnoses rely on accurate laboratory results, thereby making Quality Assurance fundamental to patient safety and clinical excellence,” Mrs. Nwakobi stated

Through the successful transition to the ISO 15189:2022 standard—the highest international benchmark for medical laboratories—EL-LAB demonstrates its unwavering commitment to excellence, impartiality, and safety. This accreditation ensures that the centre’s quality management system is not merely compliant, but a living culture of competence and continual improvement.

The system is strategically built on principles including:

Patient Centred Services
Risk-Based Thinking
Continuous Improvement

·       Staff engagement, Competence and Training

This risk-based approach ensures that all activities which pose a risk to patients are managed proactively, assuring the best possible outcomes across the entire testing process

The robust quality management strategy integrates comprehensive mechanisms to guarantee the integrity of every result. Quality assurance at EL-LAB involves the strict adherence to Standard Operating Procedures (SOPs), vigorous Internal Quality Control (IQC) checks, and mandatory validation via External Quality Assessment (EQA).

These programs ensure that every test result is accurate, reproducible, reliable, and comparable with global benchmarks, reinforcing reliability and building public trust in every report issued by the laboratory.

Addressing the 2025 Quality Week theme, “Quality: Think differently,” EL-LAB’s leadership urged healthcare professionals to challenge traditional quality approaches.

“We believe thinking differently about quality begins with one powerful shift: seeing quality not as an act, but as an attitude”. “Quality is what we do when no one is watching and it shows in how we treat our patients, our colleagues, and our work. The ISO 15189:2022 accreditation is a reminder that quality is not a destination, but a journey of continuous improvement.”

EL-LAB invites all partners, colleagues, and stakeholders in the healthcare ecosystem to join them in thinking differently, noting that the future of diagnostic excellence depends on embracing change today.

About EL-LAB Medical Diagnostics and Research Centre

Established in 1998, EL-LAB Medical Diagnostics and Research Centre is a leading ISO-certified medical laboratory providing advanced, reliable, and comprehensive diagnostic services across Nigeria. Dedicated to clinical excellence and patient safety, EL-LAB leverages state-of-the-art technology and a highly competent workforce to deliver results that form the trusted foundation of patient care.

0Shares
Continue Reading

Trending

0Shares